By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

A BRAIN implant has shown it can turn a person’s inner thoughts into words — but only if the user first thinks of a secret ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

In September 1980, a catastrophic accident unfolded at the Damascus missile complex, where a Titan II armed with a nuclear ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

HBAR could recover above $0.25 amid SWIFT blockchain trials, but the current market correction could affect its comeback.

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among ...